Concepedia

Rongzhe Liu

RL

Statistics

Publications

10

Citations

261

H-Index

10

Active since

2018

Affiliations

Pharmerit (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Columbia University

Vanderbilt University

Moffitt Cancer Center

Rongzhe Liu is an author at Pharmerit (United States) specializing in model-based economic evaluation, pharmacy, and pharmacoeconomics.

ORCID

Publications per year

2018–2023

10

Publications

10

An Xception Based Convolutional Neural Network for Scene Image Classification with Transfer Learning

Xizhi Wu, Rongzhe Liu, Hanqing Yang et al. · 2020 · 56 citations

, , +16

Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United States

Rongzhe Liu, Olalekan O. Oluwole, I. Diakité et al. · Journal of Medical Economics · 2021 · 35 citations · Full text

, , +16

Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective

Adnan Alsumali, Laurence Djatche, Andrew Briggs et al. · PharmacoEconomics · 2021 · 32 citations · Full text

, , +17

Does Biosimilar Bevacizumab Offer Affordable Treatment Options for Cancer Patients in the USA? A Budget Impact Analysis from US Commercial and Medicare Payer Perspectives

Jingyan Yang, Rongzhe Liu, V. Ektare et al. · Applied Health Economics and Health Policy · 2021 · 29 citations · Full text

, , +17

Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event

Adnan Alsumali, Dominik Lautsch, Rongzhe Liu et al. · Advances in Therapy · 2021 · 25 citations · Full text

, , +17

1–5 of 10